German Center for Neurodegenerative Diseases

German Center for Neurodegenerative Diseases DZNE
Agency overview
Formed April 2009 (April 2009)
Type Research Center
Headquarters Holbeinstraße 13-15, 53175 Bonn, Germany
50°42′4.31″N 7°8′22.06″E / 50.7011972°N 7.1394611°E / 50.7011972; 7.1394611
Employees 900
Agency executives
  • Prof. Pierluigi Nicotera, Scientific Director
  • Dr. Sabine Helling-Moegen, LL.M., Administrative Director
Website www.dzne.de

The German Center for Neurodegenerative Diseases (German: Deutsches Zentrum für Neurodegenerative Erkrankungen, DZNE) aims to develop new preventive and therapeutic approaches for neurodegenerative diseases. To accomplish this the DZNE follows a translational approach. This means that fundamental research is closely related to clinical research, population studies and health care research. In total there are nine sites all over Germany: Berlin, Bonn, Dresden, Göttingen, Magdeburg, Munich, Rostock / Greifswald, Tübingen and Witten. At each site the DZNE works closely with universities, university hospitals and other partners. The DZNE receives 90 percent of its funding from the Federal Ministry of Education and Research and 10 percent from the respective federal states containing DZNE sites.


This article is issued from Wikipedia - version of the 6/9/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.